1. Home
  2. CNTN vs AMTX Comparison

CNTN vs AMTX Comparison

Compare CNTN & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.32

Market Cap

146.5M

Sector

Health Care

ML Signal

N/A

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

N/A

Current Price

$1.83

Market Cap

134.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTN
AMTX
Founded
2017
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
146.5M
134.2M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
CNTN
AMTX
Price
$2.32
$1.83
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$12.00
AVG Volume (30 Days)
575.8K
668.9K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
88.10
32.98
EPS
N/A
N/A
Revenue
N/A
$77,194,000.00
Revenue This Year
N/A
$49.77
Revenue Next Year
N/A
$57.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
174.60
52 Week Low
$1.75
$1.30
52 Week High
$5.27
$3.80

Technical Indicators

Market Signals
Indicator
CNTN
AMTX
Relative Strength Index (RSI) 55.56 52.14
Support Level $2.14 $1.37
Resistance Level $2.40 $1.85
Average True Range (ATR) 0.16 0.10
MACD 0.02 -0.01
Stochastic Oscillator 77.43 19.11

Price Performance

Historical Comparison
CNTN
AMTX

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: